Your browser doesn't support javascript.
loading
Thirty-Day Readmission Among Patients With Uncomplicated Choledocholithiasis: A Nationwide Readmission Database Analysis.
Wang, Yichen; Murphy, Dermot; Li, Si; Chen, Bing; Peluso, Heather; Sondhi, Vikram; Abougergi, Marwan S.
Afiliação
  • Wang Y; Mercy Internal Medicine Service, Trinity Health of New England, Springfield, MA.
  • Murphy D; Mercy Internal Medicine Service, Trinity Health of New England, Springfield, MA.
  • Li S; Department of Internal Medicine, Wright Center for Graduate Medical Education, Scranton, PA.
  • Chen B; Department of Medicine, Mount Sinai Morningside and West, New York City, NY.
  • Peluso H; Department of Surgery, Prisma Health Upstate, Greenville.
  • Sondhi V; Mercy Internal Medicine Service, Trinity Health of New England, Springfield, MA.
  • Abougergi MS; Division of Gastroenterology, Department of Internal Medicine, University of South Carolina School of Medicine, Columbia.
J Clin Gastroenterol ; 57(6): 624-630, 2023 07 01.
Article em En | MEDLINE | ID: mdl-35648885
ABSTRACT
BACKGROUND AND

AIM:

We aimed to determine the rate of 30-day hospital readmissions of uncomplicated choledocholithiasis and its impact on mortality and health care use in the United States.

METHODS:

Nonelective admissions for adults with uncomplicated choledocholithiasis were selected from the Nationwide Readmission Database 2016-2018. The primary outcome was the all-cause 30-day readmission rate. Secondary outcomes were reasons for readmission, readmission mortality rate, procedures, and resource use (length of stay and total hospitalization costs and charges). Independent risk factors for readmission were identified using Cox regression analysis.

RESULTS:

The 30-day rate of readmission was 9.3%. Biliary and pancreatic disorders and postprocedural complications accounted for 36.6% and 10.3% of readmission, respectively. The mortality rate among patients readmitted to the hospital was higher than that for index admissions (2.0% vs. 0.4%, P <0.01). Readmitted patients were less likely to receive endoscopic retrograde cholangiopancreatography (61% vs. 69%, P <0.01) and laparoscopic cholecystectomy (12.5% vs. 26%, P <0.01) during the index admissions. A total of 42,150 hospital days was associated with readmission, and the total health care in-hospital economic burden was $112 million (in costs) and $470 million (in charges). Independent predictors of readmission were male sex, Medicare (compared with private) insurance, higher Elixhauser Comorbidity Index score, no endoscopic retrograde cholangiopancreatography or laparoscopic cholecystectomy, postprocedural complications of the digestive system, hemodynamic or respiratory support, urban hospitals, and lower hospital volume of uncomplicated choledocholithiasis.

CONCLUSIONS:

The uncomplicated choledocholithiasis 30-day readmission rate is 9.3%. Readmission was associated with higher mortality, morbidity, and resource use. Multiple independent predictors of readmission were identified.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Readmissão do Paciente / Coledocolitíase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Clin Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Readmissão do Paciente / Coledocolitíase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Clin Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos